好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Efficacy of Interferon-b1b on CD4+CD25+high Regulatory T Cells and Expression of FoxP3 in Multiple Sclerosis: A 2-Year Follow-Up Study
MS and Related Diseases
(-)
040
Authors/Disclosures
Yuko Shimizu, MD, PhD (Tokyo Women'S Medical University School of Medicine) Dr. Shimizu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Biogen Japan.. Dr. Shimizu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis Pharma. Dr. Shimizu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Chigai Pharma CoLtd.
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file